Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials

No abstract is available for this paper.

• Publication year

  2005

• Venue

  JAMA Internal Medicine

• Publication date

  2005-06-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHINTE.165.12.1410
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

  2004influential reference
• Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial.

  2004cited by this paper
• Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV

  2004cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

  2003cited by this paper
• Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy

  2003cited by this paper
• The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.

  2003cited by this paper
• Literature alert

  2003cited by this paper
• Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.

  2003cited by this paper
• Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

  2003cited by this paper
• Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970-1994.

  2003cited by this paper
• A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

  2003cited by this paper
• 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

  2003cited by this paper
• Diabetes-related morbidity and mortality in a national sample of U.S. elders.

  2002cited by this paper
• Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid Atherosclerosis: Principal Results of the European Lacidipine Study on Atherosclerosis (ELSA), a Randomized, Double-Blind, Long-Term Trial

  2002cited by this paper
• Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

  2002cited by this paper
• Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

  2002cited by this paper
• Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials?

  2002cited by this paper
• Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.

  2002cited by this paper
• The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function.

  2001cited by this paper
• Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials.

  2001cited by this paper
• Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

  2001cited by this paper
• Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

  2001cited by this paper
• Usefulness of Nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study). NIsoldipine in COronary artery disease in LEuven.

  2001cited by this paper
• Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

  2000cited by this paper
• Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.

  2000cited by this paper
• THE EFFECT OF NISOLDIPINE AS COMPARED WITH ENALAPRIL ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES AND HYPERTENSION

  2000cited by this paper
• Long-Term Effects of Cholesterol Lowering and Angiotensin-Converting Enzyme Inhibition on Coronary Atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT)

  2000cited by this paper
• Effect of Amlodipine on the Progression of Atherosclerosis and the Occurrence of Clinical Events

  2000cited by this paper
• Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

  1999cited by this paper
• Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

  1999cited by this paper
• Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.

  1998cited by this paper
• Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

  1998cited by this paper
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

  1998cited by this paper
• Systolic Hypertension in the Elderly: Long‐Term Lacidipine Treatment: Objective, Protocol, and Organization

  1994cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• Efficacy and Safety of ARB-Based Combination Therapies for Treatment of Hypertension: A Systematic Review and Meta-analyses.

  2026cites this paper
• Pharmacotherapy for hypertension in adults 60 years or older.

  2025cites this paper
• Unravelling the association of glycosylated haemoglobin A1c, blood pressure, and LDL-cholesterol (ABC) with all-cause mortality in Type 2 diabetes patients: insights from a middle-income country.

  2025cites this paper
• A precision trial case study for heterogeneous treatment effects in obstructive sleep apnea

  2025cites this paper
• Network meta analysis of contributions by different healthcare practitioners in digital self care for hypertension

  2025cites this paper
• Rationale, Design, and Intervention Development of a Mobile Health–Led Primary Care Program for Management of Type 2 Diabetes in Rural Thailand: Protocol for a SMARThealth Diabetes Study

  2024cites this paper
• Effect of a multicomponent quality improvement strategy on sustained achievement of diabetes care goals and macrovascular and microvascular complications in South Asia at 6.5 years follow-up: Post hoc analyses of the CARRS randomized clinical trial

  2024cites this paper
• Blood pressure management in type 2 diabetes: a review of recent evidence

  2024cites this paper
• Adherence to Lifestyle Recommendations among Adults Attending Hypertension Clinics in Selected Hospitals in Tanzania: A Cross-Sectional Study.

  2024cites this paper
• Effect of low-volume combined aerobic and resistance high-intensity interval training on vascular health in people with type 2 diabetes: a randomised controlled trial

  2024cites this paper
• A Practical Approach to the Management of Residual Cardiovascular Risk: United Arab Emirates Expert Consensus Panel on the Evidence for Icosapent Ethyl and Omega-3 Fatty Acids

  2024cites this paper
• A network meta-analysis comparative the efficacy of angiotensin-converting enzyme inhibitors and calcium channel blockers in hypertension

  2024cites this paper
• The Development and Validation of the “Hippocratic Hypertension Self-Care Scale”

  2023cites this paper
• Treatment effect modification due to comorbidity: Individual participant data meta-analyses of 120 randomised controlled trials

  2023cites this paper
• Long-term quality-of-care score for predicting the occurrence of acute myocardial infarction in patients with type 2 diabetes mellitus

  2023cites this paper
• Evaluating Drug Effectiveness for Antihypertensives in Heart Failure Prognosis: Leveraging Composite Clinical Endpoints and Biomarkers from Electronic Health Records

  2023cites this paper
• What Differentiates Rural and Urban Patients with Type 1 Diabetes—A Pilot Study

  2023cites this paper
• 2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association

  2023cites this paper
• Evaluation of the Safety and Efficacy of Dual Therapy Perindopril/Amlodipine in the Management of Hypertension. A Systematic Review and Meta-Analysis

  2022cites this paper
• Potential Gains in Life Expectancy Associated With Achieving Treatment Goals in US Adults With Type 2 Diabetes

  2022cites this paper
• The combined effects of telmisartan and ramipril on hypertension and cardiovascular injury

  2022cites this paper
• Hypertension and Diabetes

  2022cites this paper
• Individualising intensive systolic blood pressure reduction in hypertension using computational trial phenomaps and machine learning: a post-hoc analysis of randomised clinical trials

  2022cites this paper
• Acute Effects of High-Intensity Interval Training on Diabetes Mellitus: A Systematic Review

  2022influential citation
• Reduced efficacy of blood pressure lowering drugs in the presence of diabetes mellitus—results from the TRIUMPH randomised controlled trial

  2022cites this paper
• Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

  2022cites this paper
• Calcium channel blockers versus other classes of drugs for hypertension.

  2022cites this paper
• Evaluation of medication adherence and its relevant factors among hypertensive patients: A cross-sectional study in Shahrekord health-care system

  2022cites this paper
• HIIE Protocols Promote Better Acute Effects on Blood Glucose and Pressure Control in People with Type 2 Diabetes than Continuous Exercise

  2022cites this paper
• The role of sex and gender in hypertension

  2022cites this paper
• Contralesional angiotensin type 2 receptor activation contributes to recovery in experimental stroke.

  2022cites this paper
• Investigating myocardial infarction and its effects in patients with urgent medical problems using advanced data mining tools

  2021cites this paper
• An electronic decision support‐based complex intervention to improve management of cardiovascular risk in primary health care: a cluster randomised trial (INTEGRATE)

  2021cites this paper
• Impacts of type 2 diabetes mellitus and hypertension on the incidence of cardiovascular diseases and stroke in China real-world setting: a retrospective cohort study

  2021cites this paper
• VHRM_A_285907 337..348

  2021cites this paper
• Appraisal of Guidelines for the Management of Blood Pressure in Patients with Diabetes Mellitus: The Consensuses, Controversies and Gaps

  2021cites this paper
• Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers: which class of drugs should be preferable for patients with cardiovascular pathology?

  2021cites this paper
• Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension

  2021cites this paper
• Handgrip Strength Is an Independent Predictor of Cardiovascular Outcomes in Diabetes Mellitus.

  2021cites this paper
• Aspirin in primary prevention of cardiovascular disease in diabetes

  2021cites this paper
• HYPERTENSION IN RELATION TO IMMUNE SYSTEM AND WAY OF LIFE ALONG WITH TREATMENT

  2021cites this paper
• Principles of Diabetes Care and Lifestyle Modification

  2021cites this paper
• Calcium channel blockers versus other classes of drugs for hypertension.

  2021cites this paper
• Time to remove hypertension from our vocabulary?

  2021cites this paper
• 2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea

  2021cites this paper
• Similar Adaptations to 10 Weeks Concurrent Training on Metabolic Markers and Physical Performance in Young, Adult, and Older Adult Women

  2021cites this paper
• The Effects of Glucagon-Like Peptide-1 Receptor Agonists and Dipeptydilpeptidase-4 Inhibitors on Blood Pressure and Cardiovascular Complications in Diabetes

  2021cites this paper
• Differences in U.S. Rural-Urban Trends in Diabetes ABCS, 1999–2018

  2021cites this paper
• β-Blockade for Patients with Hypertension, Ischemic Heart Disease or Heart Failure: Where are We Now?

  2021cites this paper
• RMHP_A_271133 1655..1659

  2020cites this paper
• The Benefits of Including Hummus and Hummus Ingredients into the American Diet to Promote Diet Quality and Health: A Comprehensive Review

  2020cites this paper
• INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH CLASS OF ANTIHYPERTENSIVE MEDICINE PRODUCTS TO PREFER?

  2020cites this paper
• Recent Guideline for the Management of Hypertension in Patients with Diabetes

  2020cites this paper
• Management Strategies for Patients After CABG Surgery in the Outbreak of the COVID-19 Pandemic

  2020cites this paper
• Risk factors of deaths related to cardiovascular diseases in World Health Organization (WHO) member countries.

  2020cites this paper
• Managing Hypertension in the elderly: What’s new?

  2020cites this paper
• Value of ambulatory blood pressure measurement in diagnosing hypotension in hypertensive diabetic patients with medication-controlled BP

  2020cites this paper
• Epidemiological studies on socioeconomic inequalities and cardiovascular disease : prevention, progression and prognosis

  2020cites this paper
• Orthostatic Hypertension: Critical Appraisal of an Overlooked Condition.

  2020cites this paper
• Influence of pre-treatment blood pressure levels on antihypertensive drug benefits in diabetics: the roadmap experience

  2020cites this paper
• Features of postoperative therapy in patients with type ІІ diabetes

  2020cites this paper
• Managing the elderly patient with hypertension: current strategies, challenges, and considerations

  2020cites this paper
• Approaches for the Management of Resistant Hypertension in 2020

  2020cites this paper
• Effects of Exercise Intervention on Adults With Both Hypertension and Type 2 Diabetes Mellitus

  2020cites this paper
• Differential Expression of the Angiotensin-(1-12)/Chymase Axis in Human Atrial Tissue.

  2020influential citation
• Effects of switching from a dipeptidyl peptidase-4 inhibitor to luseogliflozin on nocturnal blood pressure in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, blinded endpoint parallel-group comparison study

  2020cites this paper
• Alternatives to Randomized Trials for Estimating Treatment Effects

  2020cites this paper
• International Heart and Vascular Disease

  2019cites this paper
• Implications of the new 2017 American College of Cardiology/American Aeart Association Guidelines for Hypertension.

  2019cites this paper
• Impact of Blood Pressure on Presence or Absence of Chin Dimple

  2019cites this paper
• 2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations

  2019cites this paper
• Pharmacotherapy for hypertension in adults 60 years or older.

  2019cites this paper
• Mapping the Evidence on the Effectiveness of Telemedicine Interventions in Diabetes, Dyslipidemia, and Hypertension: An Umbrella Review of Systematic Reviews and Meta-Analyses

  2019cites this paper
• Mechanistic effects of SGLT2 inhibition on blood pressure in diabetes.

  2019cites this paper
• The Treatment of Arterial Hypertension

  2019cites this paper
• The importance and challenges of developing a pharmacogenetics test for hypertension.

  2019cites this paper
• Prescribing high-intensity interval exercise by RPE in individuals with type 2 diabetes: metabolic and hemodynamic responses.

  2019cites this paper
• Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials

  2019cites this paper
• Alterations in the Metabolism of Carbohydrates in Hypertensives Treated with Atenolol

  2019cites this paper
• [Thiazide and Thiazide-Like Diuretics in Therapy of Arterial Hypertension].

  2019cites this paper
• Aspirin in the primary prevention of cardiovascular disease on diabetic patients: Systematic review and meta-analysis.

  2019cites this paper
• Gastric mucosal devitalization improves blood pressure, renin and cardiovascular lipid deposition in a rat model of obesity

  2019cites this paper
• Risk Factors Management in Diabetic Patients

  2019cites this paper
• Specialized pro-resolving mediators in diabetes: novel therapeutic strategies.

  2019cites this paper
• Precision Physical Activity and Exercise Prescriptions for Disease Prevention: The Effect of Interindividual Variability Under Different Training Approaches

  2019cites this paper
• The Association Between Access To Care And Blood Pressure Control Among Individuals With Hypertension: Evidence From The Coronary Artery Risk Development In Young Adults (cardia) Cohort

  2019cites this paper
• Blood Pressure Goals Recommended by Different Guidelines

  2019cites this paper
• The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

  2019cites this paper
• The Effect of Long-term Aerobic Exercise and Training Intensity on Blood Pressure in the Elderly

  2018cites this paper
• Comparison Therapies in the Treatment of Hypertension. The ASCOT and ACCOMPLISH Trial

  2018cites this paper
• Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014.

  2018cites this paper
• Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in hypertensive patients with type 2 diabetes mellitus

  2018cites this paper
• 50 – Updated American Heart Association/American College of Cardiology; European Society of Hypertension/International Society of Hypertension Guidelines

  2018cites this paper
• Hypertension in Adults With Type 2 Diabetes: A Review of Blood Pressure Measurement Methods, Targets and Therapy.

  2018cites this paper
• Canagliflozin and Stroke in Type 2 Diabetes Mellitus

  2018cites this paper
• Contemporary Drug Treatment of Hypertension: Focus on Recent Guidelines

  2018cites this paper
• Quality of Hypertension Management in Type 2 Diabetes in India: A Multisite Prescription Audit.

  2018cites this paper
• Drug treatment of hypertension in older patients with diabetes mellitus

  2018cites this paper
• High-Intensity Interval Training as a Tool for Counteracting Dyslipidemia in Women

  2018cites this paper
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2018cites this paper